ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

Proactive Palliative Care for Patients With Ventricular Assist Devices (VAD) and Their Families

Not Applicable

Completed

Conditions: End-stage Disease
Heart Failure

Interventions: Behavioral: Palliative Care
Other: Usual Care

First Posted Date: 2011-09-01

Last Posted Date: 2013-09-06

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 18

Registration Number: NCT01427634

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Hospital-Based Phthalate Exposure in Very Low Birth Weight Neonates

Completed

Conditions: Low Birth Weight Neonates

First Posted Date: 2011-08-19

Last Posted Date: 2013-09-20

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 81

Registration Number: NCT01420029

Locations: 🇺🇸
Mount Sinai Hospital Neonatal Intensive Care Unit, New York, New York, United States

Non-Invasive Imaging of Atherosclerosis

Completed

Conditions: Atherosclerosis

First Posted Date: 2011-08-17

Last Posted Date: 2020-08-03

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 886

Registration Number: NCT01418313

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata

Not Applicable

Terminated

Conditions: Alopecia
Balding
Alopecia Areata

Interventions: Procedure: Hair transplantation
Procedure: Hypodermic needle irritation

First Posted Date: 2011-06-30

Last Posted Date: 2016-12-22

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 4

Registration Number: NCT01385839

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, Department of Dermatology Clinical Trials Center, New York, New York, United States

Effect of a Low Advanced Glycation End Products (AGE) Diet in the Metabolic Syndrome

Not Applicable

Completed

Conditions: Metabolic Syndrome

Interventions: Other: Regular AGE Diet
Other: Low AGE Diet

First Posted Date: 2011-06-01

Last Posted Date: 2015-05-08

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 383

Registration Number: NCT01363141

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy

Completed

Conditions: Head and Neck Cancer
Squamous Cell Cancer
Human Papillomavirus
Oropharyngeal Cancer

First Posted Date: 2011-05-23

Last Posted Date: 2014-04-10

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 33

Registration Number: NCT01358097

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, Otolaryngology - Head and Neck Surgery, New York, New York, United States

Emergency Department-Based Palliative Care for Advanced Cancer Patients

Not Applicable

Completed

Conditions: Advanced Cancer
Metastatic Cancer

Interventions: Other: Care as usual
Other: Early palliative care consultation

First Posted Date: 2011-05-23

Last Posted Date: 2015-06-26

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 136

Registration Number: NCT01358110

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

The Effect of Prophylactic Swallowing Exercises on Head and Neck Cancer Patients

Not Applicable

Completed

Conditions: Dysphagia

Interventions: Behavioral: Swallowing Exercise Group

First Posted Date: 2011-05-06

Last Posted Date: 2015-12-04

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 26

Registration Number: NCT01349309

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Gemcitabine, Cisplatin, Plus Lenalidomide as First-line Therapy for Patients With Metastatic Urothelial Carcinoma

Phase 1

Terminated

Conditions: Urinary Bladder Neoplasms

Interventions: Drug: Lenalidomide

First Posted Date: 2011-04-27

Last Posted Date: 2019-04-23

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 9

Registration Number: NCT01342172

Locations: 🇺🇸
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸
National Cancer Institute, Bethesda, Maryland, United States

Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium

Completed

Conditions: Squamous Cell Carcinoma of the Oral Cavity
Oropharynx
Larynx
Hypopharynx

First Posted Date: 2011-03-24

Last Posted Date: 2012-06-21

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 64

Registration Number: NCT01321892

Locations: 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy